- Home
- NOW vs MRK Comparison
NOW vs MRK Comparison
Compare NOW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOW
- MRK
- Stock Information
- Founded
- NOW 2004
- MRK 2000
- Country
- NOW United States
- MRK United States
- Employees
- NOW N/A
- MRK N/A
- Industry
- NOW Computer Software: Prepackaged Software
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- NOW Technology
- MRK Health Care
- Exchange
- NOW Nasdaq
- MRK Nasdaq
- Market Cap
- NOW 199.5B
- MRK 218.8B
- IPO Year
- NOW 2012
- MRK N/A
- Fundamental
- Price
- NOW $917.67
- MRK $87.34
- Analyst Decision
- NOW Strong Buy
- MRK Buy
- Analyst Count
- NOW 32
- MRK 14
- Target Price
- NOW $1,108.90
- MRK $103.54
- AVG Volume (30 Days)
- NOW 1.4M
- MRK 13.8M
- Earning Date
- NOW 10-29-2025
- MRK 10-30-2025
- Dividend Yield
- NOW N/A
- MRK 3.70%
- EPS Growth
- NOW 43.57
- MRK 20.41
- EPS
- NOW 7.95
- MRK 6.49
- Revenue
- NOW $12,057,000,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- NOW $20.98
- MRK $1.84
- Revenue Next Year
- NOW $18.63
- MRK $5.24
- P/E Ratio
- NOW $115.51
- MRK $13.49
- Revenue Growth
- NOW 21.11
- MRK 1.82
- 52 Week Low
- NOW $678.66
- MRK $73.31
- 52 Week High
- NOW $1,198.09
- MRK $111.58
- Technical
- Relative Strength Index (RSI)
- NOW 48.56
- MRK 59.06
- Support Level
- NOW $893.36
- MRK $86.20
- Resistance Level
- NOW $920.34
- MRK $91.00
- Average True Range (ATR)
- NOW 25.11
- MRK 2.23
- MACD
- NOW -2.74
- MRK 0.64
- Stochastic Oscillator
- NOW 31.17
- MRK 72.32
About NOW ServiceNow Inc.
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).